Host immune effectors via cell–cell contact and cytokine signaling

Host immune effectors via cell–cell contact and cytokine signaling is a comprehensive biological pathway that describes how the immune system identifies and eliminates target cells, such as those infected by pathogens or transformed into tumors (Reactome R-HSA-198933). This process involves direct physical interactions between immune cells, such as the binding of T-cell receptors to MHC complexes or the engagement of death receptors like Fas/FasL, alongside the secretion of soluble signaling molecules like cytokines and chemokines (Janeway's Immunobiology, 9th Ed). Key effector mechanisms within this pathway include the release of cytotoxic granules containing perforin and granzymes, as well as the orchestration of systemic inflammatory responses through interferons and interleukins (Nature Reviews Immunology, 2018). While not a single molecular target, this pathway serves as the fundamental framework for modern immunotherapy, where drugs like checkpoint inhibitors and CAR-T cells are designed to enhance or restore these effector functions. Dysregulation of these interactions is a hallmark of cancer evasion, chronic viral infections, and the tissue damage seen in autoimmune diseases. Consequently, therapeutic strategies often focus on specific nodes within this pathway to either boost immune surveillance in oncology or suppress pathological inflammation in rheumatology.

Other names

Immune effector mechanismsCell-mediated immunity and cytokine signalingReactome Pathway R-HSA-198933Immune cell-mediated cytotoxicity

Modulation of immune cell-mediated killing and cytokine-driven inflammatory responses by targeting specific receptors (e.g., PD-1, CTLA-4) or soluble mediators (e.g., TNF-alpha, IL-6) within the pathway.